CD2-associated protein was found to be less abundant in the deep part of the tumor, consistent with a study demonstrating the increased FN expression in silenced cells for CD2-associated protein, and the capacity of this protein to regulate migration and EMT-related pathways in CRC cells [47]. The gene discussed is CD2AP; the disease is neoplasm.